Key for crossing the BBB with nanoparticles: the rational design

Scholarly Works

• de Moraes, B. P. T.; da Silva, K. P.; Moraes-de-Souza, I. d.; Souza Gomes-Reis, G. L. d.; Saraiva, J. S. G.; Costa, M. F.; Cunha, C. M. C. d.; Almeida, M. A. P. d.; Guterres, S. S.; Pohlmann, A. R.; Immler, R.; Napoli, M.; Estato, V.; Bozza, P. T.; de Castro-Faria-Neto, H. C.; Ferrarini, S. R.; Sperandio, M.; Silva, A. R.; Gonçalves-de-Albuquerque, C. F. DHA-loaded nanocapsules enhance microcirculation and reduce inflammation in sepsis experimental model. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2026, 201, 119651. doi:10.1016/j.biopha.2026.119651
• Llorente, X.; Esteruelas, G.; García, M. L.; Souto, E. B.; Sánchez-López, E. Polymeric nanoparticles functionalized with peptides: Advanced strategies for crossing the blood-brain barrier. Advances in pharmacology (San Diego, Calif.) 2026, 105, 325–363. doi:10.1016/bs.apha.2026.03.002
• Li, X.; Li, J.; Sun, Y.; Yao, T.; Lu, Y.; Liu, S.; Li, H.; Shi, Y.; Chen, L.; Zhao, Y.; Jiang, W.; Li, Z.; Zhou, Z.; Wang, B.; Zhang, S.; Yu, H.; Lai, Y.; Lu, Q.; Li, Y.; Li, H.; Xu, Z.; Wang, G.; Zhu, Z. Engineering brain-penetrant PROTACs: Bridging molecular design and CNS delivery. Advanced drug delivery reviews 2026, 234, 115876. doi:10.1016/j.addr.2026.115876
• Naim, A.; Farooqui, A. M.; Badruddeen; Khan, M. I.; Akhtar, J.; Ahmad, A.; Ashique, S.; Islam, A. Nanoengineered phytochemicals overcome blood-brain barrier constraints in neurodegenerative disorders. Frontiers in neurology 2026, 17, 1792829. doi:10.3389/fneur.2026.1792829
• Li, Z.; Peng, Y.; Wang, Q.; Zhou, H.; Fu, X. Recent Advances in Stimuli-Responsive Iron Oxide Nanoparticles for Glioma Theranostics: Progress and Perspective. ACS Nano Medicine 2026, 1, 961–988. doi:10.1021/acsnanomed.5c00190
• Barra, T.; Bellotti, M.; Conti, M.; Auricchio, F.; Caimi, A.; Vestiti, M.; Chiesa, E.; Valiante, S. A dynamic in vitro model of blood-brain barrier: effect of different polymeric nanoparticles on the crossing ability. International journal of pharmaceutics 2026, 695, 126778. doi:10.1016/j.ijpharm.2026.126778
• Suryawanshi, T. Y.; Redkar, N.; Sharma, A.; Mishra, J.; Saxena, S.; Shukla, S. Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering. Immuno 2026, 6, 18. doi:10.3390/immuno6010018
• Zhao, Y.; Liu, C.; Zhang, X.; Gu, T.; Wang, Y.; Zuo, T.; Liu, S.; Xu, X.; Meng, H. Mechanistic and Strategic Insights into How Lipid Nanoparticles Interact with Membrane-Based Biological Barriers. ACS nano 2026, 20, 8971–9006. doi:10.1021/acsnano.5c21857
• Martinez-Martinez, N.; Carrera-Rodríguez, L.; Vargas, R.; Hernández-Munain, C.; Suñé-Pou, M.; Suñé, C. Brain delivery of lipid nanoparticles with shuttle peptides. Advances in pharmacology (San Diego, Calif.) 2026, 105, 257–323. doi:10.1016/bs.apha.2026.02.005
• Śledzikowska, Z.; Kubicka, D.; Makaruk, N.; Waszkiewicz, N. Gold nanoparticles for central nervous system drug delivery in depression: nanobiological mechanisms, pharmacokinetics and translational perspectives. Health Nanotechnology 2026, 2. doi:10.1186/s44301-026-00024-w
• Hernández-Bellido, N.; Hernández-Ainsa, S.; Köhler, R.; Ordovás, L. Nanotechnology-driven heart targeting to fulfil the potential of cardiac microRNA therapies. International journal of pharmaceutics 2026, 692, 126643. doi:10.1016/j.ijpharm.2026.126643
• Mouchtouris, N.; Amin-Hanjani, S. Pathophysiology of Cerebral Ischemia. Surgical and Interventional Treatment of Cerebral Ischemia; Springer Nature Switzerland, 2026; pp 17–21. doi:10.1007/978-3-032-08934-2_3
• Kumar, S.; Srivastava, S.; Tan, C. S.; Abohashrh, M.; Malviya, R. Correlation between oral disease and neurodegenerative disorders: Role of biological proteins for the modulation of oral-brain axis and gut-brain axis. Colloids and surfaces. B, Biointerfaces 2026, 262, 115480. doi:10.1016/j.colsurfb.2026.115480
• Patel, R.; Mevada, S.; Shukla, S.; Bhattacharya, S.; Alsaidan, O. A.; Prajapati, B. Carboxymethyl chitosan for neurological drug delivery: Current trends and future prospects. International journal of biological macromolecules 2026, 344, 150488. doi:10.1016/j.ijbiomac.2026.150488
• Kumar, S.; Malviya, R.; Sridhar, S. B.; Wadhwa, T.; Shareef, J. Artificial intelligence and machine learning driven nanorobotics for targeted brain delivery: Redefining blood-brain barrier navigation. Journal of neuroscience methods 2026, 429, 110695. doi:10.1016/j.jneumeth.2026.110695
• Lanser, D. M.; Turner, A.; Pacifici, N.; Vu, K.; Lewis, J.; Gelli, A. Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model. PloS one 2026, 21, e0340202. doi:10.1371/journal.pone.0340202
• Kushwaha, N.; Patel, A.; Akarte, K.; Shukla, N.; Li, Z.; Patel, S.; Patel, V.; Panjwani, D.; Yadav, M. R.; Joshi, A. DoE-driven development, characterisation, in-silico ADME, and evaluation of surface functionalized SPIONs for enhanced blood–brain barrier permeability and targeted delivery of S-adenosylmethionine. Journal of Nanoparticle Research 2026, 28. doi:10.1007/s11051-025-06534-5
• Xia, Q.; Mudiyanselage, S. H. B. H.; Lafond, S.; Rexha, H. In Silico Modeling of Nanoparticle Transport across the Blood–Brain Barrier: A Systematic Review. Computational and Structural Biotechnology Journal 2026, 35. doi:10.34133/csbj.0020
• Kumar, M.; Arora, D.; Jahangir, M.; Taneja, Y. Peptide-anchored nanocarrier(s) therapy for glioblastoma. Emerging Paradigms in Delivery of Therapeutic Agents for the Treatment of Glioblastoma; Elsevier, 2026; pp 225–248. doi:10.1016/b978-0-443-33319-4.00010-0
• Anand, R.; Bhattacharya, S. Poly(2-(diisopropylamino)ethyl methacrylate) as a pH-sensitive polymeric system for Colon cancer therapy. International Journal of Polymeric Materials and Polymeric Biomaterials 2025, 75, 656–682. doi:10.1080/00914037.2025.2604139

Explore citations to this article at